(Q38197726)

30 August 2017

1 reference

title

Endoscopic scoring systems for inflammatory bowel disease: pros and cons (English)

1 reference

inflammatory bowel diseases

30 August 2017

main subject

0 references

2

Raf Bisschops

0 references

Gian Eugenio Tontini

1

object named as

Gian Eugenio Tontini

0 references

author name string

Gian Eugenio Tontini

1

1 reference

30 August 2017

Raf Bisschops

2

1 reference

30 August 2017

Helmut Neumann

3

1 reference

30 August 2017

language of work or name

1 reference

20 March 2014

1 reference

Expert Review of Gastroenterology & Hepatology

30 August 2017

number of pages

12

1 reference

based on heuristic

inferred from page(s)

published in

1 reference

30 August 2017

volume

8

1 reference

30 August 2017

issue

5

1 reference

30 August 2017

page(s)

543-554

1 reference

Increasing Incidence and Prevalence of the Inflammatory Bowel Diseases With Time, Based on Systematic Review

30 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2014.899899

The burden of inflammatory bowel disease in Europe

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2014.899899

Central role of the gut epithelial barrier in the pathogenesis of chronic intestinal inflammation: lessons learned from animal models and human genetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2014.899899

European evidence based consensus for endoscopy in inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2014.899899

Results of the 2nd part Scientific Workshop of the ECCO. II: Measures and markers of prediction to achieve, detect, and monitor intestinal healing in inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2014.899899

Challenges to the design, execution, and analysis of randomized controlled trials for inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2014.899899

Clinical implications of mucosal healing in the management of patients with inflammatory bowel disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2014.899899

Mucosal healing in inflammatory bowel diseases: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2014.899899

Mucosal healing in inflammatory bowel disease: results from a Norwegian population-based cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2014.899899

A review of activity indices and efficacy end points for clinical trials of medical therapy in adults with ulcerative colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2014.899899

Review article: defining remission in ulcerative colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2014.899899

Definition and evaluation of mucosal healing in clinical practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2014.899899

Clinical implications of mucosal healing for the management of IBD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2014.899899

Cortisone in ulcerative colitis; final report on a therapeutic trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2014.899899

Development and validation of an endoscopic index of the severity for Crohn's disease: a prospective multicentre study. Groupe d'Etudes Thérapeutiques des Affections Inflammatoires du Tube Digestif (GETAID)

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2014.899899

Review article: Crohn's disease: monitoring disease activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2014.899899

Developing an instrument to assess the endoscopic severity of ulcerative colitis: the Ulcerative Colitis Endoscopic Index of Severity (UCEIS)

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2014.899899

The role of centralized reading of endoscopy in a randomized controlled trial of mesalamine for ulcerative colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2014.899899

Validation of the ulcerative colitis colonoscopic index of severity and its correlation with disease activity measures.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2014.899899

Outcome measurement in clinical trials for Ulcerative Colitis: towards standardisation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2014.899899

Reliability and initial validation of the ulcerative colitis endoscopic index of severity

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2014.899899

Endoscopic evaluation of Crohn's disease activity: comparison of the CDEIS and the SES-CD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2014.899899

Endoscopic improvement of mucosal lesions in patients with moderate to severe ileocolonic Crohn's disease following treatment with certolizumab pegol

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2014.899899

Association between plasma concentrations of certolizumab pegol and endoscopic outcomes of patients with Crohn's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2014.899899

Validation of endoscopic activity scores in patients with Crohn's disease based on a post hoc analysis of data from SONIC.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2014.899899

Adalimumab induces and maintains mucosal healing in patients with Crohn's disease: data from the EXTEND trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2014.899899

A review of activity indices and efficacy endpoints for clinical trials of medical therapy in adults with Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2014.899899

Natural history of recurrent Crohn's disease at the ileocolonic anastomosis after curative surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2014.899899

Azathioprine and mesalamine for prevention of relapse after conservative surgery for Crohn's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2014.899899

Postoperative maintenance of Crohn's disease remission with 6-mercaptopurine, mesalamine, or placebo: a 2-year trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2014.899899

Ineffectiveness of Lactobacillus johnsonii LA1 for prophylaxis of postoperative recurrence in Crohn's disease: a randomised, double blind, placebo controlled GETAID trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2014.899899

Azathioprine versus mesalazine for prevention of postoperative clinical recurrence in patients with Crohn's disease with endoscopic recurrence: efficacy and safety results of a randomised, double-blind, double-dummy, multicentre trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2014.899899

Comparison of several activity indices for the evaluation of endoscopic activity in UC: inter- and intraobserver consistency

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2014.899899

Treatment of ulcerative colitis with a humanized antibody to the alpha4beta7 integrin

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2014.899899

Coated mesalazine (5-aminosalicylic acid) versus sulphasalazine in the treatment of active ulcerative colitis: a randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2014.899899

Adalimumab induces and maintains clinical remission in patients with moderate-to-severe ulcerative colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2014.899899

Clinical, biological, and endoscopic picture of attacks of Crohn's disease. Evolution on prednisolone. Groupe d'Etude Thérapeutique des Affections Inflammatoires Digestives.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2014.899899

Clinical disease activity, C-reactive protein normalisation and mucosal healing in Crohn's disease in the SONIC trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2014.899899

Relationships between disease activity and serum and fecal biomarkers in patients with Crohn's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2014.899899

Mucosal healing predicts sustained clinical remission in patients with early-stage Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2014.899899

Short CDAI: development and validation of a shortened and simplified Crohn's disease activity index.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2014.899899

Preliminary examination of the relations between disease activity, illness perceptions, coping strategies, and psychological morbidity in Crohn's disease guided by the common sense model of illness

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2014.899899

Mucosal healing in inflammatory bowel disease: treatment efficacy and predictive factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2014.899899

The utility of biomarkers in the diagnosis and therapy of inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2014.899899

Fecal calprotectin is a surrogate marker for endoscopic lesions in inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2014.899899

Neopterin is a novel reliable fecal marker as accurate as calprotectin for predicting endoscopic disease activity in patients with inflammatory bowel diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2014.899899

Imaging of the small bowel in Crohn's disease: a review of old and new techniques.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2014.899899

Imaging techniques for assessment of inflammatory bowel disease: joint ECCO and ESGAR evidence-based consensus guidelines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2014.899899

Systematic review: the use of ultrasonography, computed tomography and magnetic resonance imaging for the diagnosis, assessment of activity and abdominal complications of Crohn's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2014.899899

Magnetic resonance imaging for evaluation of Crohn's disease: validation of parameters of severity and quantitative index of activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2014.899899

Diagnostic accuracy of magnetic resonance colonography for the evaluation of disease activity and severity in ulcerative colitis: a prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2014.899899

Accuracy of small-intestine contrast ultrasonography, compared with computed tomography enteroclysis, in characterizing lesions in patients with Crohn's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2014.899899

Adalimumab induces deep remission in patients with Crohn's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2014.899899

Mucosal healing and deep remission: what does it mean?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2014.899899

Results from the 2nd Scientific Workshop of the ECCO. I: Impact of mucosal healing on the course of inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2014.899899

Mucosal healing predicts long-term outcome of maintenance therapy with infliximab in Crohn's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2014.899899

Cancer surveillance in longstanding ulcerative colitis: endoscopic appearances help predict cancer risk.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2014.899899

Clinical Study of the Relation between Mucosal Healing and Long-Term Outcomes in Ulcerative Colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2014.899899

Infliximab for induction and maintenance therapy for ulcerative colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2014.899899

European consensus on the histopathology of inflammatory bowel disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2014.899899

Microscopic activity in ulcerative colitis: what does it mean?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2014.899899

Gross versus microscopic pancolitis and the occurrence of neoplasia in ulcerative colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2014.899899

Severity of inflammation is a risk factor for colorectal neoplasia in ulcerative colitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2014.899899

Inflammation is an independent risk factor for colonic neoplasia in patients with ulcerative colitis: a case-control study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2014.899899

Role of small-bowel endoscopy in the management of patients with inflammatory bowel disease: an international OMED-ECCO consensus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2014.899899

Initial experience with wireless capsule enteroscopy in the diagnosis and management of inflammatory bowel disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2014.899899

Validation of the Capsule Endoscopy Crohn's Disease Activity Index (CECDAI or Niv score): a multicenter prospective study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2014.899899

Development of a capsule endoscopy scoring index for small bowel mucosal inflammatory change

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2014.899899

Lewis Score: a useful clinical tool for patients with suspected Crohn's Disease submitted to capsule endoscopy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2014.899899

Video capsule endoscopy in inflammatory bowel disease: past, present, and future redux.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2014.899899

IBD: Measuring what counts--endoscopic assessment in IBD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2014.899899

Advances in novel diagnostic endoscopic imaging techniques in inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2014.899899

Advanced endoscopic imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2014.899899

Review article: newer optical and digital chromoendoscopy techniques vs. dye-based chromoendoscopy for diagnosis and surveillance in inflammatory bowel disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2014.899899

Pit patterns in rectal mucosa assessed by magnifying colonoscope are predictive of relapse in patients with quiescent ulcerative colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2014.899899

Beyond white light endoscopy: the role of optical biopsy in inflammatory bowel disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2014.899899

Confocal laser endomicroscopy: technical advances and clinical applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2014.899899

Endomicroscopy and endocytoscopy in IBD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2014.899899

Assessment of Crohn's disease activity by confocal laser endomicroscopy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2014.899899

Classification of inflammation activity in ulcerative colitis by confocal laser endomicroscopy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2014.899899

Local barrier dysfunction identified by confocal laser endomicroscopy predicts relapse in inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2014.899899

Infliximab, azathioprine, or combination therapy for Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2014.899899

Maintenance of Remission Among Patients With Crohn's Disease on Antimetabolite Therapy After Infliximab Therapy Is Stopped

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2014.899899

Adalimumab for induction of clinical remission in moderately to severely active ulcerative colitis: results of a randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2014.899899

10.1586/17474124.2014.899899

21 January 2018

Identifiers

DOI

1 reference

release_lu5gztod2nd4rah4r2skzzqkty

30 August 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/lu5gztod2nd4rah4r2skzzqkty

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference